Drivers of Performance in 2024
Pakistan
The largest contributor to fund performance in 2024 has been Pakistan, with the KSE-100 Index being the second-best performing market globally with a USD return of +88.6%. Though the start of an IMF loan program and improving economic indicators have been important drivers of returns, the key factor for the world-beating rally on the KSE-100 Index has been the aggressive interest rate cuts by the State Bank of Pakistan (SBP) as inflation has now entered the territory of low single digits.
We anticipated interest rate cuts of 600-700 basis points in 2024 and so far, the SBP has cut interest rates by 900 basis points since June 2024 because inflation has fallen at a faster pace than initially expected.
Pakistan is now the fund’s largest country weight through our increased allocation as well as stock price appreciation.
Though returns for the fund in Pakistan were broad-based, some of the key contributors to performance in Pakistan were Airlink Communication, Haleon Pakistan, and Pakistan Stock Exchange.
Airlink’s stock price witnessed a big rally as it increased its local assembly of mobile phones for key brands like Xiaomi while also bringing online the assembly of Xiaomi Smart TVs. Furthermore, the company also won a contract to assemble Acer laptops and tablets.
The fund’s holding in Haleon Pakistan (its previous name was GlaxoSmithKline Consumer Healthcare), which is the Pakistan subsidiary of Haleon PLC, was the best-performing stock for the fund in terms of stock price performance and the third largest contributor to performance in Pakistan. Like in many countries, Haleon Pakistan’s products are household names with brands like Panadol, Sensodyne, and ENO. Besides the company’s powerful brands doing well, the key trigger for the exponential re-rating in its stock price was the lifting of price controls by the government for non-essential drugs, which is very positive for Pakistan’s pharmaceutical industry.
Besides the company’s powerful brands doing well, the key trigger for the exponential re-rating in its stock price was the lifting of price controls by the government for non-essential drugs, which is very positive for Pakistan’s pharmaceutical industry.
The stock price of the Pakistan Stock Exchange witnessed a big rally, which is not surprising given the very positive investor sentiment leading to significantly higher trading volumes on the exchange. Pakistan Stock Exchange has been a multi-bagger for the fund, as we initially purchased this name in March 2023 at a price PKR 8.0 per share – this is almost a 2x return in less than 2 years.
|